Fideuram Asset Management Ireland dac Takes $957,000 Position in Oscar Health, Inc. $OSCR

Posted by Geri Gentry on May 31st, 2026

Fideuram Asset Management Ireland dac acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 60,000 shares of the company’s stock, valued at approximately $957,000.

Several other institutional investors and hedge funds have also recently modified their holdings of OSCR. Thrive Capital Management LLC increased its position in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. bought a new stake in Oscar Health in the first quarter worth $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Oscar Health by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after purchasing an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp increased its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 0.4%

OSCR stock opened at $22.24 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $25.58. The stock has a market capitalization of $6.71 billion, a price-to-earnings ratio of -37.70, a price-to-earnings-growth ratio of 1.55 and a beta of 2.34. The firm’s fifty day simple moving average is $17.38 and its two-hundred day simple moving average is $15.77.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. During the same quarter in the previous year, the business posted $0.92 earnings per share. The business’s revenue was up 52.6% compared to the same quarter last year. As a group, analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Insiders Place Their Bets

In other Oscar Health news, CFO Richard Scott Blackley sold 100,000 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer owned 1,216,660 shares in the company, valued at $28,177,845.60. The trade was a 7.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini acquired 1,000,000 shares of the business’s stock in a transaction on Monday, April 6th. The shares were purchased at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the transaction, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at approximately $121,546,761.92. The trade was a 10.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on OSCR. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Tuesday, April 21st. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a research report on Thursday, February 12th. UBS Group boosted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Robert W. Baird boosted their price target on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Finally, Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and boosted their price target for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $19.22.

Get Our Latest Stock Analysis on Oscar Health

Oscar Health Company Profile

(Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.